litlas
ログインアカウント作成

Yoshiya Tanaka

1988–2025 年に発表

349
論文数
38,753
被引用数
103
h 指数
314
i10 指数

被引用数

Yoshiya Tanaka の年別被引用数1984 年: 被引用 1 件1989 年: 被引用 1 件1990 年: 被引用 4 件1991 年: 被引用 4 件1992 年: 被引用 21 件1993 年: 被引用 86 件1994 年: 被引用 108 件1995 年: 被引用 99 件1996 年: 被引用 89 件1997 年: 被引用 83 件1998 年: 被引用 80 件1999 年: 被引用 88 件2000 年: 被引用 66 件2001 年: 被引用 57 件2002 年: 被引用 65 件2003 年: 被引用 55 件2004 年: 被引用 35 件2005 年: 被引用 42 件2006 年: 被引用 45 件2007 年: 被引用 41 件2008 年: 被引用 33 件2009 年: 被引用 55 件2010 年: 被引用 69 件2011 年: 被引用 70 件2012 年: 被引用 128 件2013 年: 被引用 157 件2014 年: 被引用 160 件2015 年: 被引用 187 件2016 年: 被引用 181 件2017 年: 被引用 248 件2018 年: 被引用 252 件2019 年: 被引用 997 件2020 年: 被引用 1,525 件2021 年: 被引用 1,467 件2022 年: 被引用 1,461 件2023 年: 被引用 1,335 件2024 年: 被引用 2,252 件2025 年: 被引用 1,273 件2026 年: 被引用 21 件1985〜1988 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,042 件、この内訳の 19.3%中国: 引用元論文 1,614 件、この内訳の 10.2%日本: 引用元論文 1,208 件、この内訳の 7.7%イギリス: 引用元論文 1,166 件、この内訳の 7.4%ドイツ: 引用元論文 838 件、この内訳の 5.3%イタリア: 引用元論文 791 件、この内訳の 5%フランス: 引用元論文 591 件、この内訳の 3.8%カナダ: 引用元論文 556 件、この内訳の 3.5%オランダ: 引用元論文 482 件、この内訳の 3.1%スペイン: 引用元論文 422 件、この内訳の 2.7%オーストラリア: 引用元論文 390 件、この内訳の 2.5%スイス: 引用元論文 284 件、この内訳の 1.8%
0%19.3%その他 27.7%

機関

分野

  • Medicine73%
  • Biochemistry, Genetics and Molecular Biology13%
  • Immunology and Microbiology10.2%
  • Neuroscience1.3%
  • Pharmacology, Toxicology and Pharmaceutics0.6%
  • Engineering0.5%
  • その他1.4%

トピック

  • Rheumatoid Arthritis Research and Therapies7.6%
  • Systemic Lupus Erythematosus Research7.1%
  • T-cell and B-cell Immunology3.2%
  • Spondyloarthritis Studies and Treatments2.8%
  • Autoimmune and Inflammatory Disorders Research2.6%
  • Cytokine Signaling Pathways and Interactions2.5%
  • その他74.2%

共著者

全論文

検索で開く
  1. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

    著者: Antonis Fanouriakis, Myrto Kostopoulou, Jeanette Andersen, Martin Aringer, Laurent Arnaud, Sang‐Cheol Bae, John Boletis, Ian N Bruce, Ricard Cervera, Andrea Doria, Thomas Dörner, Richard Furie, Dafna D. Gladman, Frédéric Houssiau, Luís Inês, David Jayne, Marios Kouloumas, László Kovács, Chi Chiu Mok, Eric F. Morand, Gabriella Moroni, Marta Mosca, Johanna Mücke, Chetan Mukhtyar, György Nagy, Sandra Navarra, Ioannis Parodis, José María Pego‐Reigosa, Michelle Petri, Bernardo A. Pons‐Estel, Matthias Schneider, Josef S Smolen, Elisabet Svenungsson, Yoshiya Tanaka, Maria G. Tektonidou, Y K Onno Teng, Anǵela Tincani, Edward M Vital, Ronald van Vollenhoven, Chris Wincup, George Βertsias, Dimitrios T. Boumpas - Annals of the Rheumatic Diseases 2023 被引用: 933

  2. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

    著者: Martin Aringer, Karen H. Costenbader, David Daikh, Ralph Brinks, Marta Mosca, Rosalind Ramsey‐Goldman, Josef S Smolen, David Wofsy, Dimitrios T. Boumpas, Diane L. Kamen, David Jayne, Ricard Cervera, N. Costedoat‐Chalumeau, Betty Diamond, Dafna D. Gladman, Bevra Hahn, Falk Hiepe, Søren Jacobsen, Dinesh Khanna, Kirsten Lerstrøm, Elena Massarotti, Joseph M. McCune, Guillermo Ruiz‐Irastorza, Jorge Sánchez‐Guerrero, Matthias Schneider, Murray B. Urowitz, George Βertsias, Bimba F. Hoyer, Nicolai Leuchten, Chiara Tani, Sara K. Tedeschi, Zahi Touma, Gabriela Schmajuk, Branimir Anić, Florence Assan, Tak Mao Chan, Ann E. Clarke, Mary K. Crow, László Czirják, Andrea Doria, W. Graninger, Bernadett Halda-Kiss, Sarfaraz Hasni, Peter Izmirly, Michelle Jung, Gabór Kumánovics, Xavier Mariette, Ivan Padjen, José María Pego‐Reigosa, Juanita Romero‐Díaz, Íñigo Rúa‐Figueroa Fernández, Raphaèle Séror, Georg Stummvoll, Yoshiya Tanaka, Maria G. Tektonidou, Carlos Vasconcelos, Edward M Vital, Daniel J. Wallace, Şule Yavuz, Pier Luigi Meroni, Marvin J. Fritzler, Ray Naden, Thomas Dörner, Sindhu R. Johnson - Annals of the Rheumatic Diseases 2019 被引用: 2,515

  3. Trial of Anifrolumab in Active Systemic Lupus Erythematosus

    著者: Eric F. Morand, Richard Furie, Yoshiya Tanaka, Ian N Bruce, Anca Askanase, Christophe Richez, Sang‐Cheol Bae, Philip Z. Brohawn, Lilia Pineda, Anna Berglind, Raj Tummala - New England Journal of Medicine 2019 被引用: 1,326

  4. Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach

    著者: Yoshiya Tanaka, Yiming Luo, John J. O’Shea, Shingo Nakayamada - Nature Reviews Rheumatology 2022 被引用: 487

  5. Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

    著者: Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst, Jonathan Goldin, Grace Kim, Masataka Kuwana, Yannick Allanore, Marco Matucci‐Cerinic, Oliver Distler, Yoshihito Shima, Jacob M. van Laar, Helen Spotswood, Bridget K. Wagner, Jeffrey Siegel, Angelika Jahreis, Christopher P. Denton, Eleonora Lucero, Bernardo A. Pons‐Estel, Mariano Rivero, Guillermo Tate, Vanessa Smith, Ellen De Langhe, Rasho Rashkov, Anastas Batalov, I Goranov, Румен Стоилов, James V. Dunne, Sindhu R. Johnson, Janet Pope, Dušanka Martinović Kaliterna, Mette Mogensen, Anne Braae Olesen, Yannick Allanore, J. Henes, Ulf Müller‐Ladner, Gabriela Riemekasten, Alla Skapenko, Panayiotis G. Vlachoyiannopoulos, Emese Kiss, Tünde Minier, Lorenzo Beretta, Elisa Gremese, Marco Matucci‐Cerinic, Gabriele Valentini, Yoshihide Asano, Tatsuya Atsumi, Hironobu Ihn, Tomonori Ishii, Osamu Ishikawa, Masataka Kuwana, Yoshihito Shima, Hiroki Takahashi, Kazuhiko Takehara, Yoshiya Tanaka, Yoshioki Yamasaki, Loreta Bukauskienė, İrena Butrimienė, Gabriel Medrano Ramírez, César Ramos-Remus, Tatiana Sofía Rodríguez Reyna, Jeska de Vries‐Bouwstra, Jacob M. van Laar, Bogdan Batko, Sławomir Jeka, Eugeniusz J. Kucharz, Maria Majdan, Marzena Olesińska, Żaneta Smoleńska, José Delgado Alves, María José Santos, C. Mihai, Simona Rednic, Ivan Castellvi Barranco, Francisco Longo, C Simeόn Aznar, Patrícia Carreira, Oliver Distler, Ulrich A. Walker, Emma Derrett‐Smith, Bridget Griffiths, Neil D McKay, Christopher P. Denton, Jacob Aelion, Michael Borofsky, Roy Fleischmann, Joseph Z. Forstot, Daniel E. Furst, Suzanne Kafaja, Mahmuda Khan, Dinesh Khanna, Michael Kohen, Richard W. Martin, Fabian Mendoza-Ballesteros, Alireza Nami, Shirley Pang, Grissel Ríos, Robert W. Simms, Keith M. Sullivan, Virginia Steen - The Lancet Respiratory Medicine 2020 被引用: 652

  6. Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis

    著者: Kazuyoshi Ishigaki, Saori Sakaue, Chikashi Terao, Yang Luo, Kyuto Sonehara, Kensuke Yamaguchi, Tiffany Amariuta, Chun Lai Too, Vincent A. Laufer, Ian C. Scott, Sébastien Viatte, Meiko Takahashi, Koichiro Ohmura, Akira Murasawa, Motomu Hashimoto, Hiromu Ito, Samer Hammoudeh, Samar Al Emadi, Basel Masri, Hussein Halabi, Humeira Badsha, Imad Uthman, Xin Wu, Lin Li, Ting Li, Darren Plant, Anne Barton, Gisela Orozco, Suzanne Verstappen, John Bowes, Alex J. MacGregor, Suguru Honda, Masaru Koido, Kohei Tomizuka, Yoichiro Kamatani, Hiroaki Tanaka, Eiichi Tanaka, Akari Suzuki, Yuichi Maeda, Kenichi Yamamoto, Satoru Miyawaki, Gang Xie, Jinyi Zhang, Christopher I. Amos, Edward Keystone, Gertjan Wolbink, Irene van der Horst‐Bruinsma, Jing Cui, Katherine P. Liao, Robert J. Carroll, Hye‐Soon Lee, So‐Young Bang, Katherine Siminovitch, Niek de Vries, Lars Alfredsson, Solbritt Rantapää‐Dahlqvist, Elizabeth W. Karlson, Sang‐Cheol Bae, Robert P. Kimberly, Jeffrey C. Edberg, Xavier Mariette, T. Huizinga, Philippe Dieudé, Matthias Schneider, Martin Kerick, Joshua C. Denny, The BioBank Japan Project, Koichi Matsuda, Keitaro Matsuo, Tsuneyo Mimori, Fumihiko Matsuda, Keishi Fujio, Yoshiya Tanaka, Atsushi Kumanogoh, Matthew Traylor, Cathryn M. Lewis, Stephen Eyre, Huji Xu, Richa Saxena, Thurayya Arayssi, Yuta Kochi, Katsunori Ikari, Masayoshi Harigai, Peter K. Gregersen, Kazuhiko Yamamoto, S. Louis Bridges, Leonid Padyukov, Javier Martı́n, Lars Klareskog, Yukinori Okada, Soumya Raychaudhuri - Nature Genetics 2022 被引用: 348

  7. Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis

    著者: Peter C. Taylor, Edward Keystone, Désirée van der Heijde, Michael E. Weinblatt, Liliana Morales, Jaime Reyes Gonzaga, S. S. Yаkushin, Taeko Ishii, Kahaku Emoto, Scott D. Beattie, Vipin Arora, C. Gaich, Terence Rooney, Douglas Schlichting, William L. Macias, Stephanie de Bono, Yoshiya Tanaka - New England Journal of Medicine 2017 被引用: 951

  8. Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis

    著者: Gerd R Burmester, Stanley Cohen, Kevin Winthrop, Peter Nash, Alan D. Irvine, Atul Deodhar, Eduardo Mysler, Yoshiya Tanaka, John Liu, Ana P. Lacerda, Hannah Palac, Tim Shaw, Philip J. Mease, Emma Guttman‐Yassky - RMD Open 2023 被引用: 210

  9. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update

    著者: Laure Gossec, Andreas Kerschbaumer, Ricardo J O Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, Wolf‐­Henning Boehncke, Bente Appel Esbensen, Iain B. McInnes, Dennis McGonagle, Kevin Winthrop, Andra Bălănescu, P Bálint, Gerd R Burmester, Juan D. Cañete, Pascal Claudepierre, Lihi Eder, Merete Lund Hetland, Annamaria Iagnocco, Lars Erik Kristensen, Rik Lories, Rubén Queiró, Daniele Mauro, Helena Marzo‐Ortega, Philip J. Mease, Peter Nash, Wendy Wagenaar, L. Savage, Georg Schett, Stephanie Shoop-Worrall, Yoshiya Tanaka, Filip Van den Bosch, Annette H M van der Helm–van Mil, Alen Zabotti, Désirée van der Heijde, Josef S Smolen - Annals of the Rheumatic Diseases 2024 被引用: 331

  10. Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE)

    著者: Joseph F. Merola, Robert Landewé, Iain B. McInnes, Philip J. Mease, Christopher T Ritchlin, Yoshiya Tanaka, Akihiko Asahina, Frank Behrens, Dafna D. Gladman, Laure Gossec, Alice B. Gottlieb, Diamant Thaçi, Richard B. Warren, Barbara Ink, Deepak Assudani, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Laura C. Coates - The Lancet 2022 被引用: 158

  11. Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial

    著者: Bernard Combe, Alan Kivitz, Yoshiya Tanaka, Désirée van der Heijde, J. Simón, Herbert S. B. Baraf, Uma Kumar, F. Matzkies, Beatrix Bartók, Lei Ye, Ying Guo, Chantal Tasset, John S. Sundy, Angelika Jahreis, Mark C. Genovese, Neelufar Mozaffarian, Robert Landewé, Sang‐Cheol Bae, Edward C. Keystone, Peter Nash - Annals of the Rheumatic Diseases 2021 被引用: 247

  12. Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme

    著者: Stanley Cohen, Ronald van Vollenhoven, Kevin Winthrop, Cristiano A. F. Zerbini, Yoshiya Tanaka, Louis Bessette, Ying Zhang, Nasser Khan, Barbara A. Hendrickson, Jeffrey Enejosa, Gerd R Burmester - Annals of the Rheumatic Diseases 2020 被引用: 233

  13. A Randomized, Placebo‐Controlled Phase III Extension Trial of the Long‐Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus

    著者: Kenneth Kalunian, Richard Furie, Eric F. Morand, Ian N Bruce, Susan Manzi, Yoshiya Tanaka, Kevin Winthrop, Ihor Hupka, Lijin Zhang, Shanti Werther, Gabriel Abreu, Micki Hultquist, Raj Tummala, Catharina Lindholm, Hussein Al‐Mossawi - Arthritis & Rheumatology 2022 被引用: 152

  14. Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement

    著者: Peter Nash, Andreas Kerschbaumer, Thomas Dörner, Maxime Dougados, Roy Fleischmann, Klaus Geißler, Iain B. McInnes, Janet Pope, Désirée van der Heijde, Michaela Stoffer, Tsutomu Takeuchi, Michael Trauner, Kevin Winthrop, Maarten de Wit, Daniel Aletaha, Xenofon Baraliakos, Wolf‐­Henning Boehncke, Paul Emery, John D. Isaacs, Joel M. Kremer, Eun Bong Lee, Walter P. Maksymowych, Marieke Voshaar, Lai‐Shan Tam, Yoshiya Tanaka, Filip Van den Bosch, René Westhovens, Ricardo Machado Xavier, Josef S Smolen - Annals of the Rheumatic Diseases 2020 被引用: 288

  15. Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study

    著者: Josef S Smolen, Aileen L. Pangan, Paul Emery, William F. C. Rigby, Yoshiya Tanaka, Juan Ignacio Vargas, Ying Zhang, Nemanja Damjanov, Alan Friedman, Mohamed I. A. Othman, Heidi S. Camp, Stanley Cohen - The Lancet 2019 被引用: 378

  16. Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II)

    著者: Michelle Petri, Ian N Bruce, Thomas Dörner, Yoshiya Tanaka, Eric F. Morand, Kenneth Kalunian, Mario H. Cardiel, Maria Silk, Christina Dickson, Gabriella Meszaros, Lu Zhang, Bochao Jia, Youna Zhao, Conor J McVeigh, Marta Mosca - The Lancet 2023 被引用: 165

  17. JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial

    著者: Katherine R Tuttle, Frank C. Brosius, Sharon G. Adler, Matthias Kretzler, Ravindra L. Mehta, James A. Tumlin, Yoshiya Tanaka, Masakazu Haneda, Jiajun Liu, Maria Silk, Tracy Cardillo, Kevin L. Duffin, Joseph V. Haas, William L. Macias, Fabio P. Nunes, Jonathan Janes - Nephrology Dialysis Transplantation 2017 被引用: 277

  18. Treatment of lupus nephritis: consensus, evidence and perspectives

    著者: Chi Chiu Mok, Y K Onno Teng, Ramesh Saxena, Yoshiya Tanaka - Nature Reviews Rheumatology 2023 被引用: 134

  19. Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial

    著者: Daniel J. Wallace, Richard Furie, Yoshiya Tanaka, Kenneth Kalunian, Marta Mosca, Michelle Petri, Thomas Dörner, Mario H. Cardiel, Ian N Bruce, Elisa Gómez, Tara Carmack, Amy M. DeLozier, Jonathan Janes, Matthew D. Linnik, Stephanie de Bono, Maria Silk, Robert W. Hoffman - The Lancet 2018 被引用: 513

  20. Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programme

    著者: Stanley Cohen, Yoshiya Tanaka, Xavier Mariette, Jeffrey R. Curtis, Eun Bong Lee, Peter Nash, Kevin Winthrop, Christina Charles‐Schoeman, Lisy Wang, Connie Chen, Kenneth Kwok, Pinaki Biswas, Andrea Shapiro, Ann Madsen, J. Wollenhaupt - RMD Open 2020 被引用: 181

  21. Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-Associated Vasculitis

    著者: Shunsuke Furuta, Daiki Nakagomi, Y Kobayashi, Masaki Hiraguri, Takao Sugiyama, Koichi Amano, Takeshi Umibe, Hajime Kono, Kazuhiro Kurasawa, Yasuhiko Kita, Ryutaro Matsumura, Yuko Kaneko, Keita Ninagawa, Keiju Hiromura, Shin‐ichiro Kagami, Yosuke Inaba, Hideki Hanaoka, Kei Ikeda, Hiroshi Nakajima, LoVAS Collaborators, Kengo Nagashima, Yohei Kawasaki, Yoshito Ozawa, Kokoro Someya, Asako Kono, Daisuke Kashiwakuma, Hiroshi Watanabe, Tamao Nakashita, Norihiro Mimura, Yoshihiro Oya, Michio Fujiwara, Ichiei Narita, Yoko Wada, Takeshi Nakatsue, Noriyoshi Ogawa, Daisuke Suzuki, Kurumi Asako, Hirotoshi Kikuchi, Shunya Uchida, Yoshihide Fujigaki, Toru Sakairi, Reika Maezawa, Hirotoshi Kawashima, Ayako Matsuki, M. Yamagata, Yuichiro Ohta, Ryota Sakai, Tomonori Ishii, Atsushi Kawakami, Takayuki Sumida, Norihiko Watanabe, Tatsuya Atsumi, Shun Tanimura, Atsushi Kumanogoh, Takahiko Sugihara, Hideyuki Iwai, Yoshiya Tanaka, Atsushi Komatsuda, Kaori Ito, Y. Shimojima, Iwao Sekigawa, Yukiko Takakuwa, Yuichi Makino, Ryusuke Yoshimi, Taichi Hayashi, Hiroshi Otani - JAMA 2021 被引用: 217

  22. Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)

    著者: Iain B. McInnes, Akihiko Asahina, Laura C. Coates, Robert Landewé, Joseph F. Merola, Christopher T Ritchlin, Yoshiya Tanaka, Laure Gossec, Alice B. Gottlieb, Richard B. Warren, Barbara Ink, Deepak Assudani, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Philip J. Mease - The Lancet 2022 被引用: 157

  23. Anifrolumab efficacy and safety by type I interferon gene signature and clinical subgroups in patients with SLE: post hoc analysis of pooled data from two phase III trials

    著者: Edward M Vital, Joan T. Merrill, Eric F. Morand, Richard Furie, Ian N Bruce, Yoshiya Tanaka, Susan Manzi, Kenneth Kalunian, Rubana N. Kalyani, Katie Streicher, Gabriel Abreu, Raj Tummala - Annals of the Rheumatic Diseases 2022 被引用: 142

  24. Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims Databases

    著者: Claudia A. Salinas, Anthony Louder, Jennifer M. Polinski, Tancy C. Zhang, Hannah Bower, Syd Phillips, Yu‐Fei Song, Emaan Rashidi, Rafia Bosan, Hsiu‐Ching Chang, Nicole C. Foster, Bernice Gershenson, Hisashi Yamanaka, Mitsumasa Kishimoto, Yoshiya Tanaka, Peter Fischer, Baojin Zhu, Douglas E. Faries, Xiaodan Mai, Brett T. Doherty, Angela Grelaud, Nicolas H. Thurin, Johan Askling, Walter Deberdt - Rheumatology and Therapy 2022 被引用: 98